These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 15060970)
1. [Osteoporosis: an example of an integrating medicine]. Lamy O Praxis (Bern 1994); 2004 Feb; 93(9):309. PubMed ID: 15060970 [No Abstract] [Full Text] [Related]
3. [Therapeutic strategies for osteoporosis]. Chapurlat R; Delmas PD Ann Med Interne (Paris); 2000 Oct; 151(6):471-6. PubMed ID: 11104926 [TBL] [Abstract][Full Text] [Related]
4. [Guidelines for the diagnosis, prevention and treatment of osteoporosis. Italian Osteoporosis, Mineral Metabolism, and Skeletal Diseases Society]. Società Italiana dell'Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro Minerva Endocrinol; 2013 Mar; 38(1 Suppl 1):1-30. PubMed ID: 23539106 [No Abstract] [Full Text] [Related]
9. Bisphosphonates in the treatment of osteoporosis. Principles and efficacy. Papapoulos SE Ann Med Interne (Paris); 2000 Oct; 151(6):504-10. PubMed ID: 11104931 [No Abstract] [Full Text] [Related]
10. [Osteoporosis priority: Reduce the number of fractures]. Roux C Presse Med; 2006 Oct; 35(10 Pt 2):1527-8. PubMed ID: 17028516 [No Abstract] [Full Text] [Related]
11. Can the prophylactic use of raloxifene, a selective estrogen-receptor modulator, prevent bone mineral loss and fractures in women with diagnosed osteoporosis or vertebral fractures? Rosenfeld JA West J Med; 2000 Sep; 173(3):186-8. PubMed ID: 10986186 [No Abstract] [Full Text] [Related]
12. [First choice drug for treatment of osteoporosis and the strategic points for choice of drugs]. Soen S Nihon Rinsho; 2007 Nov; 65 Suppl 9():325-8. PubMed ID: 18159713 [No Abstract] [Full Text] [Related]
14. [A good combination to achieve a reduced number of fractures: bone density measurements, drug therapy and hip protector]. Johnell O; Ljunggren O; Mellström D Lakartidningen; 2001 Jul; 98(28-29):3204-6. PubMed ID: 11496807 [No Abstract] [Full Text] [Related]
15. [Prevention of fractures with therapeutic agents for osteoporosis]. Hosoi T Nihon Rinsho; 2004 Feb; 62 Suppl 2():596-601. PubMed ID: 15035197 [No Abstract] [Full Text] [Related]
16. Reduction of vertebral fracture risk with raloxifene. Bashore R J Fam Pract; 1999 Nov; 48(11):911-2. PubMed ID: 10907630 [No Abstract] [Full Text] [Related]